Literature DB >> 11705935

Distribution and genetic diversity of suilysin in Streptococcus suis isolated from different diseases of pigs and characterization of the genetic basis of suilysin absence.

S J King1, P J Heath, I Luque, C Tarradas, C G Dowson, A M Whatmore.   

Abstract

Streptococcus suis is an economically important pathogen of pigs responsible for a variety of diseases including meningitis, septicemia, arthritis, and pneumonia, although little is known about the mechanisms of pathogenesis or virulence factors associated with this organism. Here, we report on the distribution and genetic diversity of the putative virulence factor suilysin, a member of the thiol-activated toxin family of gram-positive bacteria. On the basis of PCR analysis of over 300 isolates of S. suis, the suilysin-encoding gene, sly, was detected in 69.4% of isolates. However, sly was present in a considerably higher proportion of isolates obtained from cases of meningitis, septicemia, and arthritis (>80%) and isolates obtained from asymptomatic tonsillar carriage (>90%) than lung isolates associated with pneumonia (44%). With the exception of serotypes 1, 14, and 1/14, there was no strong correlation between the presence of suilysin and serotype. Analysis of the genetic diversity of suilysin by restriction fragment length polymorphism and sequence analysis found that the suilysin gene, where present, is highly conserved with a maximum of 1.79% diversity at the nucleotide level seen between sly alleles. Assays of hemolytic activity and hybridization analysis provided no evidence for a second member of the thiol-activated toxin family in S. suis. Inverse PCR was used to characterize regions flanking sly, which in turn allowed the first characterization of the equivalent region in a strain lacking sly. Sequence comparison of these regions from sly-positive (P1/7) and sly-negative (DH5) strains indicated that two alternative arrangements are both flanked by genes with highest similarity to haloacid dehalogenase-like hydrolases (5' end) and putative N-acetylmannosamine-6-phosphate epimerases (3' end). However, sly appears to be completely absent from the alternative arrangement, and a gene of unknown function is located in the equivalent position. Finally, PCR analysis of multiple sly-positive and -negative strains indicated that these two alternative genetic arrangements are conserved among many S. suis isolates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705935      PMCID: PMC98849          DOI: 10.1128/IAI.69.12.7572-7582.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Suilysin production by Streptococcus suis strains isolated from diseased and healthy carrier pigs in Spain.

Authors:  C Tarradas; C Borge; A Arenas; A Maldonado; R Astorga; A Miranda; I Luque
Journal:  Vet Rec       Date:  2001-02-10       Impact factor: 2.695

2.  Streptococcus suis serotypes 3 to 28 associated with disease in pigs.

Authors:  P J Heath; B W Hunt
Journal:  Vet Rec       Date:  2001-02-17       Impact factor: 2.695

3.  The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity.

Authors:  M Pinkney; E Beachey; M Kehoe
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

4.  Isolation and characterization of Streptococcus suis capsular types 9-22.

Authors:  M Gottschalk; R Higgins; M Jacques; M Beaudoin; J Henrichsen
Journal:  J Vet Diagn Invest       Date:  1991-01       Impact factor: 1.279

5.  Relatedness of Streptococcus suis isolates of various serotypes and clinical backgrounds as evaluated by macrorestriction analysis and expression of potential virulence traits.

Authors:  A Allgaier; R Goethe; H J Wisselink; H E Smith; P Valentin-Weigand
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection.

Authors:  N P Cianciotto; B I Eisenstein; C H Mody; G B Toews; N C Engleberg
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

7.  Meningitis caused by Streptococcus suis in humans.

Authors:  J P Arends; H C Zanen
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

8.  Streptococcus suis serotype 2 mutants deficient in capsular expression.

Authors:  N Charland; J Harel; M Kobisch; S Lacasse; M Gottschalk
Journal:  Microbiology (Reading)       Date:  1998-02       Impact factor: 2.777

9.  Serology of capsulated streptococci pathogenic for pigs: six new serotypes of Streptococcus suis.

Authors:  B Perch; K B Pedersen; J Henrichsen
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

10.  Description of 14 new capsular types of Streptococcus suis.

Authors:  M Gottschalk; R Higgins; M Jacques; K R Mittal; J Henrichsen
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

View more
  28 in total

1.  Viral Coinfection Replaces Effects of Suilysin on Streptococcus suis Adherence to and Invasion of Respiratory Epithelial Cells Grown under Air-Liquid Interface Conditions.

Authors:  Georg Herrler; Nai-Huei Wu; Peter Valentin-Weigand; Fandan Meng; Jie Tong; Désirée Vötsch; Ju-Yi Peng; Xuehui Cai; Maren Willenborg
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  NanA, a neuraminidase from Streptococcus pneumoniae, shows high levels of sequence diversity, at least in part through recombination with Streptococcus oralis.

Authors:  Samantha J King; Adrian M Whatmore; Christopher G Dowson
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

3.  First report of the multiresistance gene cfr in Streptococcus suis.

Authors:  Yang Wang; Dexi Li; Li Song; Yang Liu; Tao He; Hebing Liu; Congming Wu; Stefan Schwarz; Jianzhong Shen
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

4.  Human infective endocarditis caused by Streptococcus suis serotype 2.

Authors:  Martin C Heidt; Walid Mohamed; Torsten Hain; Paul Robert Vogt; Trinad Chakraborty; Eugen Domann
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Distribution of capsular serotypes and virulence markers of Streptococcus suis isolated from pigs with polyserositis in Korea.

Authors:  Duyeol Kim; Kiwon Han; Yeonsu Oh; Chung Hyun Kim; Ikjae Kang; Jeehoon Lee; Marcelo Gottschalk; Chanhee Chae
Journal:  Can J Vet Res       Date:  2010-10       Impact factor: 1.310

6.  Genetic and virulence characterization of Streptococcus suis type 2 isolates from swine in the provinces of Zhejiang and Henan, China.

Authors:  Yulong Tang; Huancan Zhao; Wei Wu; Di Wu; Xiaoliang Li; Weihuan Fang
Journal:  Folia Microbiol (Praha)       Date:  2011-11-15       Impact factor: 2.099

Review 7.  Autopsy report of four cases who died from Streptococcus suis infection, with a review of the literature.

Authors:  Q-P Yang; W-P Liu; L-X Guo; Y Jiang; G-D Li; Y-Q Bai; S-H Li; T Wu; H-Q Jing
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-29       Impact factor: 3.267

8.  Identification of an inducible bacteriophage in a virulent strain of Streptococcus suis serotype 2.

Authors:  J Harel; G Martinez; A Nassar; H Dezfulian; S J Labrie; R Brousseau; S Moineau; M Gottschalk
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Genetic diversity of Streptococcus suis serotype 2 isolated from pigs in Brazil.

Authors:  Daniela Sabatini Doto; Luisa Zanolli Moreno; Franco Ferraro Calderaro; Carlos Emilio Cabrera Matajira; Vasco Tulio de Moura Gomes; Thais Sebastiana Porfida Ferreira; Renan Elias Mesquita; Jorge Timenetsky; Marcelo Gottschalk; Andrea Micke Moreno
Journal:  Can J Vet Res       Date:  2016-04       Impact factor: 1.310

10.  Distribution, genetic diversity, and variable expression of the gene encoding hyaluronate lyase within the Streptococcus suis population.

Authors:  Samantha J King; Andrew G Allen; Duncan J Maskell; Christopher G Dowson; Adrian M Whatmore
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.